Common use of Scientific Records Clause in Contracts

Scientific Records. Each Party shall maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent and regulatory purposes, which shall fully and properly reflect all work done and results achieved in the performance of the Development activities, Clinical Studies and Secondary Indication Studies with respect to each Licensed Product by such Party.

Scientific Records. Each Party shall will maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent Patent and regulatory purposespurposes and in compliance with cGLP with respect to activities intended to be submitted in regulatory filings (including INDs and BLAs), which shall fully and properly will reflect all material work done and results achieved in the performance of the Development activities, activities and Clinical Studies and Secondary Indication Studies with respect to each Global Antibody Candidates and Global Licensed Product Products by such Party.

Scientific Records. Each Party shall will maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent Patent and regulatory purposespurposes and in compliance with cGLP with respect to activities intended to be submitted in regulatory filings (including INDs and BLAs), which shall will fully and properly accurately reflect all work done and results achieved in the performance of the Development activities, Clinical Studies Studies, Regional [***] Activities and Secondary Indication Supplemental Studies with respect to each Regional Antibody Candidates and Regional Licensed Product Products by such Party.

Scientific Records. Each Party shall will maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent Patent and regulatory purposespurposes and in compliance with GLP, GCP and GMP, as applicable, with respect to activities intended to be submitted in regulatory filings, which shall will fully and properly accurately reflect all work done and results achieved in the performance of the Development activities, Clinical Studies Studies, and Secondary Indication Supplemental Studies with respect to each Licensed Product Products by such Party.

Scientific Records. Each Party shall will maintain scientific records, records in sufficient detail and in sound good scientific manner appropriate for patent and regulatory purposes, and in compliance with GLP, cGMP, and GCP with respect to activities intended to be submitted in regulatory filings (including INDs), all of which shall records will fully and properly accurately reflect all work done and results achieved in the performance of the Development activities, activities and Clinical Studies and Secondary Indication Studies by or on behalf of such Party with respect to Collaboration Compounds, Collaboration Products, and Companion Diagnostics directed to each Licensed Product by such PartyCollaboration Target.

Scientific Records. Each Party shall will maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent Patent and regulatory purposespurposes and in compliance with GCP, as applicable, with respect to activities intended to be submitted in Regulatory Filings, which shall will fully and properly accurately reflect all work done and results achieved in the performance of the Development activities, activities and Clinical Studies and Secondary Indication Studies with respect to each Licensed Product Products in the Field in the Shionogi Territory by such Party.

Scientific Records. Each Party shall will maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent Patent and regulatory purposespurposes and in compliance with cGLP with respect to activities that require cGLP compliance to be submitted in regulatory filings (including INDs and BLAs), which shall fully and properly will accurately reflect all work done and results achieved in the performance of the Development activities, Clinical Studies Studies, and Secondary Indication Studies with respect to each Licensed Product by such PartySupplemental Studies.

Scientific Records. Each Party shall will maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent Patent and regulatory purposespurposes and in compliance with GLP, GCP and GMP, as applicable, with respect to all Development activities, and the results of such activities, intended to support or be submitted in regulatory filings covering Licensed Product, which shall records will fully and properly accurately reflect and document all work done and results achieved in the performance of the Development activities, Clinical Studies Studies, and Secondary Indication Supplemental Studies with respect to each Licensed Product Products by such PartyParty under this Agreement.

Scientific Records. Each Party shall will maintain scientific records, in sufficient detail and in sound scientific manner appropriate for patent Patent and regulatory purposespurposes and in compliance with GLP, GCP and GMP, as applicable, with respect to activities intended to be submitted in Regulatory Filings for any Licensed Product, which shall will fully and properly accurately reflect all work done and results achieved in the performance of the Development activities, Clinical Studies Studies, and Secondary Indication Supplemental Studies with respect to each Licensed Product Products by such Party.